A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis (TB), researchers reported this week in the New ...

A WOMAN who was fit, healthy and active, working out seven days a week, is now wheelchair-bound and having palliative care in ...

Drug-susceptibility testing for bedaquiline ... clofazimine, delamanid, any fluoroquinolone, or linezolid. The per-protocol population included participants from the modified intention-to-treat ...

One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster.